Some of Jomboy Media's best trivia minds attempt to name players on the batter strikeouts since 2000 list. The catch? The ...
Chris Rose and Trevor Plouffe discuss the hottest stories in baseball Monday through Friday! Thanks to our partners at ...
Investigational TAK-881 was comparable to established HYQVIA while also demonstrating reduced infusion volume and duration for PID patientsOSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE ...
Zahed emphasised that for some of these individuals, the gravity of their actions exceeds a standard murder case, raising the ...
Journalist leader Syed Abdal Ahmed has been appointed as the principal information officer (PIO) of the Press Information ...
Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...
Cricket betting expert Ed Hawkins has a preview with betting tips for Sunrisers Hyderabad v Punjab Kings and he is expecting ...
On 9 April 2026 the Company announced the declaration of an interim dividend in respect of the period from 1 January 2026 to 31 March 2026 of 1 ...
Click Therapeutics is cutting staff just days after announcing a new funding round and taking over commercial work for its experimental digital therapeutic, CT-155. The cuts were confirmed to Fierce ...
Boehringer Ingelheim and Click Therapeutics are restructuring their marketing deal for the software-based schizophrenia treatment CT-155, as the German pharma also opens its coffers. Under what the ...
Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type in the US for preventing attacks in people with episodic migraine. The ...